Raniben en es it fr

Raniben Brand names, Raniben Analogs

Raniben Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Raniben Chemical_Formula


Raniben RX_link


Raniben fda sheet

Raniben FDA

Raniben msds (material safety sheet)

Raniben MSDS

Raniben Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Raniben Molecular Weight

314.405 g/mol

Raniben Melting Point

69-70 oC

Raniben H2O Solubility

24.7 mg/mL

Raniben State


Raniben LogP


Raniben Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Raniben Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Raniben Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Raniben Absorption

Approximately 50% bioavailability orally.

Raniben side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Raniben Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Raniben Organisms Affected

Humans and other mammals